The U.S. Food and Drug Administration has taken steps that prevent certain vaccine safety studies from being published, igniting a debate about transparency and public trust. Researchers, patient advocates, and lawmakers say the move could hamper scientific scrutiny and weaken the systems that monitor vaccine risks. What the agency did …